Filing Details
- Accession Number:
- 0001209191-15-042229
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-13 16:05:52
- Reporting Period:
- 2015-05-11
- Filing Date:
- 2015-05-13
- Accepted Time:
- 2015-05-13 16:05:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1578251 | T. Jeffrey Walsh | C/O Bluebird Bio, Inc. 150 Second Street Cambridge MA 02141 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-05-11 | 10,455 | $2.09 | 10,455 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2015-05-11 | 545 | $2.09 | 11,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-05-11 | 1,120 | $160.80 | 9,880 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-05-11 | 2,593 | $161.96 | 7,287 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-05-11 | 1,715 | $162.83 | 5,572 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-05-11 | 1,328 | $164.06 | 4,244 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-05-11 | 1,121 | $165.24 | 3,123 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-05-11 | 1,901 | $166.41 | 1,222 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-05-11 | 1,222 | $167.26 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2015-05-11 | 10,455 | $0.00 | 10,455 | $2.09 |
Common Stock | Stock Otpion (right to buy) | Disposition | 2015-05-11 | 545 | $0.00 | 545 | $2.09 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
60,733 | 2021-07-13 | No | 4 | M | Direct | |
12,780 | 2021-07-13 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 26, 2014.
- The range of prices for the transaction reported on this line was $160.41 to $161.41. The average weighted price was $160.8035. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $161.43 to $162.43. The average weighted price was $161.9571. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $162.44 to $163.32. The average weighted price was $162.8321. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $163.47 to $164.46. The average weighted price was $164.0553. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $164.78 to $165.56. The average weighted price was $165.2362. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $166.01 to $166.95. The average weighted price was $166.4062. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $167.0250 to $167.52. The average weighted price was $167.2585. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This option vests over a four-year period, at a rate of twenty-five percent (25%) on May 16, 2012 and in 36 equal monthly installments thereafter.